Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-26

Clinical Trial Update: Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating the safety and tolerability of cannabidiol in individuals with opioid use disorder on methadone or buprenorphine; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Yale University | Conditions: Addiction | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-11-26